SciELO - Scientific Electronic Library Online

 
vol.31 número2Determinación de la carga viral del VIH-1 en muestras de sangre seca en papel de filtroDeterminación de la capacidad promotora del crecimiento vegetal de Tsukamurella paurometabola C-924 y caracterización de los principales mecanismos involucrados en el proceso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Biotecnología Aplicada

versão On-line ISSN 1027-2852

Resumo

SAUREZ-MARTINEZ, Giselle  e  BENCOMO-YANES, Anamary. Nimotuzumab, effective immunotherapy for the treatment of malignant epithelial tumors. Biotecnol Apl [online]. 2014, vol.31, n.2, pp.159-167. ISSN 1027-2852.

Nimotuzumab, a humanized monoclonal antibody, is a novel drug against the epidermal growth factor receptor, which is a protein that is highly expressed in malignant tumors of epithelial origin. This paper presents its physicochemical and pharmaceutical characteristics, the results of pre-clinical and clinical research, and the international regulations for the diseases for which its use has been indicated: in advanced head and neck tumors, malignant brain tumors in adults and children, and advanced esophagus tumors. Its safety profile, efficacy and effectiveness studied before and after its regulatory approval are also described. Finally, recommendations are given for its dosage according to clinical evidence, for the appropriate therapeutic use of this medication.

Palavras-chave : epidermal growth factor receptor; nimotuzumab; cancer treatment; targeted therapy; biological therapy.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )